Depending on essential activities of PDK1 in tumor cells, analysts lately demonstrated that PDK1 acts as an appropriate therapeutic tool for anticancer and established multiple PDK1 blockers, including AR-12 and GSK233447, for the killing of cancerous cells (Peifer and Alessi, 2008). Here, PDK1 is linked to neoplasm.